Cargando…

Identifying zoonotic origin of SARS-CoV-2 by modeling the binding affinity between Spike receptor-binding domain and host ACE2

Despite considerable research progress on SARS-CoV-2, the direct zoonotic origin (intermediate host) of the virus remains ambiguous. The most definitive approach to identify the intermediate host would be the detection of SARS-CoV-2-like coronaviruses in wild animals. However, due to the high number...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Xiaoqiang, Zhang, Chengxin, Pearce, Robin, Omenn, Gilbert S., Zhang, Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491519/ https://www.ncbi.nlm.nih.gov/pubmed/32935105 http://dx.doi.org/10.1101/2020.09.11.293449

Ejemplares similares

Mechanistic Origin of Different Binding Affinities of SARS-CoV and SARS-CoV-2 Spike RBDs to Human ACE2
por: Zhang, Zhi-Bi, et al.
Publicado: (2022)

Effect of An 84-bp Deletion of the Receptor-Binding Domain on the ACE2 Binding Affinity of the SARS-CoV-2 Spike Protein: An In Silico Analysis
por: Kemenesi, Gábor, et al.
Publicado: (2021)

In silico comparison of SARS-CoV-2 spike protein-ACE2 binding affinities across species and implications for virus origin
por: Piplani, Sakshi, et al.
Publicado: (2021)

High affinity binding of SARS-CoV-2 spike protein enhances ACE2 carboxypeptidase activity
por: Lu, Jinghua, et al.
Publicado: (2020)

High affinity binding of SARS-CoV-2 spike protein enhances ACE2 carboxypeptidase activity
por: Lu, Jinghua, et al.
Publicado: (2020)

Computationally engineered ACE2 decoy binds with nanomolar affinity with the SARS-CoV-2 spike protein
por: Islam, Mohammad S., et al.
Publicado: (2022)

Author Correction: In silico comparison of SARS-CoV-2 spike protein-ACE2 binding affinities across species and implications for virus origin
por: Piplani, Sakshi, et al.
Publicado: (2021)

De novo design of protein peptides to block association of the SARS-CoV-2 spike protein with human ACE2
por: Huang, Xiaoqiang, et al.
Publicado: (2020)

Chloroquine and Hydroxychloroquine Interact Differently with ACE2 Domains Reported to Bind with the Coronavirus Spike Protein: Mediation by ACE2 Polymorphism
por: Badraoui, Riadh, et al.
Publicado: (2021)

Impact of temperature on the affinity of SARS-CoV-2 Spike glycoprotein for host ACE2
por: Prévost, Jérémie, et al.
Publicado: (2021)

SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity
por: Ozono, Seiya, et al.
Publicado: (2021)

Spike residue 403 affects binding of coronavirus spikes to human ACE2
por: Zech, Fabian, et al.
Publicado: (2021)

Identification of 13 Guanidinobenzoyl- or Aminidinobenzoyl-Containing Drugs to Potentially Inhibit TMPRSS2 for COVID-19 Treatment
por: Huang, Xiaoqiang, et al.
Publicado: (2021)

Immunoglobulin yolk targeting spike 1, receptor binding domain of spike glycoprotein and nucleocapsid of SARS-CoV-2 blocking RBD-ACE2 binding interaction
por: Eka Saputri, Meliana, et al.
Publicado: (2022)

Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding
por: Byrnes, James R., et al.
Publicado: (2020)

Development of a nano-luciferase based assay to measure the binding of SARS-CoV-2 spike receptor binding domain to ACE-2
por: Lima, Marcelo A., et al.
Publicado: (2021)

Atomistic insights into the binding of SARS-CoV-2 spike receptor binding domain with the human ACE2 receptor: The importance of residue 493
por: Carter, Camryn, et al.
Publicado: (2023)

Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity
por: Chakraborty, Sandipan
Publicado: (2021)

Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity
por: Chakraborty, Sandipan
Publicado: (2021)

Spike protein receptor-binding domains from SARS-CoV-2 variants of interest bind human ACE2 more tightly than the prototype spike protein
por: Charles, Jermilia, et al.
Publicado: (2023)

Harnessing coronavirus spike proteins' binding affinity to ACE2 receptor through a novel baculovirus surface display system
por: Wang, Lin, et al.
Publicado: (2022)

SARS-CoV-2 spike and ACE2 entanglement-like binding
por: Pregnolato, Massimo, et al.
Publicado: (2023)

Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics
por: Barton, Michael I, et al.
Publicado: (2021)

Computational prediction of the effect of amino acid changes on the binding affinity between SARS-CoV-2 spike RBD and human ACE2
por: Chen, Chen, et al.
Publicado: (2021)

A CNN model for predicting binding affinity changes between SARS-CoV-2 spike RBD variants and ACE2 homologues
por: Chen, Chen, et al.
Publicado: (2022)

Endocytosis of the receptor-binding domain of SARS-CoV spike protein together with virus receptor ACE2
por: Wang, Shunxin, et al.
Publicado: (2008)

Structural insights into the binding of SARS-CoV-2, SARS-CoV, and hCoV-NL63 spike receptor-binding domain to horse ACE2
por: Lan, Jun, et al.
Publicado: (2022)

Altered hACE2 binding affinity and S1/S2 cleavage efficiency of SARS-CoV-2 spike protein mutants affect viral cell entry
por: Wang, Ke, et al.
Publicado: (2023)

A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor
por: Rajpoot, Sajjan, et al.
Publicado: (2021)

Modeling SARS-CoV-2 spike/ACE2 protein–protein interactions for predicting the binding affinity of new spike variants for ACE2, and novel ACE2 structurally related human protein targets, for COVID-19 handling in the 3PM context
por: Tragni, Vincenzo, et al.
Publicado: (2022)

Identification of hACE2-interacting sites in SARS-CoV-2 spike receptor binding domain for antiviral drugs screening
por: Hu, Xiaopeng, et al.
Publicado: (2022)

Correlating the differences in the receptor binding domain of SARS-CoV-2 spike variants on their interactions with human ACE2 receptor
por: Mahalingam, Gokulnath, et al.
Publicado: (2023)

Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2
por: Chan, Kui K., et al.
Publicado: (2020)

The sequence of human ACE2 is suboptimal for binding the S spike protein of SARS coronavirus 2
por: Procko, Erik
Publicado: (2020)

Revealing the Mechanism of SARS-CoV-2 Spike Protein Binding With ACE2
Publicado: (2020)

Mechanism and evolution of human ACE2 binding by SARS-CoV-2 spike
por: Wrobel, Antoni G.
Publicado: (2023)

SARS-CoV-2 B.1.1.7 and B.1.351 Spike variants bind human ACE2 with increased affinity
por: Ramanathan, Muthukumar, et al.
Publicado: (2021)

SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity
por: Ramanathan, Muthukumar, et al.
Publicado: (2021)

Biophysical properties of the isolated spike protein binding helix of human ACE2
por: Das, Anirban, et al.
Publicado: (2021)

Synthetic carbohydrate-binding agents neutralize SARS-CoV-2 by inhibiting binding of the spike protein to ACE2
por: Francesconi, Oscar, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tnbefq58kqj21g8a31ouq34va6